Search all trials

Find therapies in clinical trials near you – page 8

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Indolent systemic mastocytosis

Recruiting

Investigational

Study of TL-895 for Patients with Relapsed or Refractory Myelofibrosis or Indolent Systemic Mastocytosis

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:1-4-{[6-Amino-5-(4-Phenoxy-Phenyl)-Pyrimidin-4-Ylamino]-Methyl}-4-Fluoro-Piperidin-1-Yl)-Propenone

Contact Research Centre

Acute lymphocytic leukaemia

Recruiting

Registered drugNo placebo

Study of Ponatinib and Chemotherapy for Adults with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia

Registered drugNo placebo

Italy

Participants:18–64 years
Substances:Cyclophosphamide

Contact Research Centre

Chronic lymphocytic leukaemia

Recruiting

Registered drugNo placebo

Study of venetoclax, obinutuzumab and zanubrutinib combination therapy in young patients with high-risk Chronic Lymphocytic Leukemia and residual disease

Registered drugNo placebo

Italy

Participants:18–64 years
Substances:Allopurinol

Contact Research Centre

Dementia Alzheimer's type

Recruiting

Registered drug

Study on the Effects of Rotigotine and Rivastigmine in Patients with Mild to Moderate Alzheimer's Disease

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Rotigotine

Contact Research Centre

Study Comparing Odronextamab with Rituximab and Chemotherapy for Patients with Untreated Follicular Lymphoma

Recruiting

Registered drugNo placebo

Study Comparing Odronextamab with Rituximab and Chemotherapy for Patients with Untreated Follicular Lymphoma

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide

Contact Research Centre

Partial lipodystrophy

Recruiting

Registered drugNo placebo

Study on the Effects of Metreleptin for Patients with Partial Lipodystrophy

Registered drugNo placebo

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:Metreleptin

Contact Research Centre

Follicular lymphoma

Recruiting

Registered drugNo placebo

Study on Radiotherapy Alone or with Obinutuzumab for Patients with Early Stage Follicular Lymphoma

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Obinutuzumab

Contact Research Centre

Plasma cell myeloma

Recruiting

Registered drugNo placebo

Study on Monitoring Untreated Multiple Myeloma in Patients Using Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone or a New Drug Combination

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

Mantle cell lymphoma

Recruiting

Registered drugNo placebo

Study of Venetoclax, Ibrutinib, and Rituximab or Bendamustine Combination for Patients with Untreated Mantle Cell Lymphoma Not Suitable for High-Dose Therapy

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Bendamustine

Contact Research Centre

Hodgkin's disease

Recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Tislelizumab for Patients with Newly Diagnosed Hodgkin Lymphoma Who Cannot Have Standard Chemotherapy

Registered drugNo placebo

Italy

Participants:65+ years
Substances:Tislelizumab

Contact Research Centre

Breast cancer metastatic

Recruiting

InvestigationalNo placebo

Study on Lasofoxifene, Fulvestrant, and Abemaciclib for Advanced Breast Cancer in Women and Men with ESR1 Mutation

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Abemaciclib

Contact Research Centre

Chronic lymphocytic leukaemia+1

Recruiting

Registered drugNo placebo

Study on Ibrutinib and Venetoclax for Patients with Untreated Chronic Lymphocytic Leukemia

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Ibrutinib

Contact Research Centre

Find therapies in clinical trials near you – page 8

244 trials match your criteria

Indolent systemic mastocytosis

Study of TL-895 for Patients with Relapsed or Refractory Myelofibrosis or Indolent Systemic Mastocytosis

Acute lymphocytic leukaemia

Study of Ponatinib and Chemotherapy for Adults with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia

Chronic lymphocytic leukaemia

Study of venetoclax, obinutuzumab and zanubrutinib combination therapy in young patients with high-risk Chronic Lymphocytic Leukemia and residual disease

Dementia Alzheimer's type

Study on the Effects of Rotigotine and Rivastigmine in Patients with Mild to Moderate Alzheimer's Disease

Study Comparing Odronextamab with Rituximab and Chemotherapy for Patients with Untreated Follicular Lymphoma

Study Comparing Odronextamab with Rituximab and Chemotherapy for Patients with Untreated Follicular Lymphoma

Partial lipodystrophy

Study on the Effects of Metreleptin for Patients with Partial Lipodystrophy

Follicular lymphoma

Study on Radiotherapy Alone or with Obinutuzumab for Patients with Early Stage Follicular Lymphoma

Plasma cell myeloma

Study on Monitoring Untreated Multiple Myeloma in Patients Using Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone or a New Drug Combination

Mantle cell lymphoma

Study of Venetoclax, Ibrutinib, and Rituximab or Bendamustine Combination for Patients with Untreated Mantle Cell Lymphoma Not Suitable for High-Dose Therapy

Hodgkin's disease

Study on the Effectiveness and Safety of Tislelizumab for Patients with Newly Diagnosed Hodgkin Lymphoma Who Cannot Have Standard Chemotherapy

Breast cancer metastatic

Study on Lasofoxifene, Fulvestrant, and Abemaciclib for Advanced Breast Cancer in Women and Men with ESR1 Mutation

Chronic lymphocytic leukaemia+1

Study on Ibrutinib and Venetoclax for Patients with Untreated Chronic Lymphocytic Leukemia

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.